Literature DB >> 34787461

Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization.

Viktoria Kolbe1, Wing H Ip1, Lisa Kieweg-Thompson1, Judith Lang1, Julia Gruhne1, Tina Meyer1, Britta Wilkens1, Marcel Schie2,3, Roland Thünauer2, Sabrina Schreiner4,5,6, Luca D Bertzbach1, Estefanía Rodríguez1,7,8, Thomas Dobner1.   

Abstract

Over the past decades, studies on the biology of human adenoviruses (HAdVs) mainly focused on the HAdV prototype species C type 5 (HAdV-C5) and revealed fundamental molecular insights into mechanisms of viral replication and viral cell transformation. Recently, other HAdV species are gaining more and more attention in the field. Reports on large E1B proteins (E1B-55K) from different HAdV species showed that these multifactorial proteins possess strikingly different features along with highly conserved functions. In this work, we identified potential SUMO-conjugation motifs (SCMs) in E1B-55K proteins from HAdV species A to F. Mutational inactivation of these SCMs demonstrated that HAdV E1B-55K proteins are SUMOylated at a single lysine residue that is highly conserved among HAdV species B to E. Moreover, we provide evidence that E1B-55K SUMOylation is a potent regulator of intracellular localization and p53-mediated transcription in most HAdV species. We also identified a lysine residue at position 101 (K101), which is unique to HAdV-C5 E1B-55K and specifically regulates its SUMOylation and nucleo-cytoplasmic shuttling. Our findings reveal important new aspects on HAdV E1B-55K proteins and suggest that different E1B-55K species possess conserved SCMs while their SUMOylation has divergent cellular effects during infection. IMPORTANCE E1B-55K is a multifunctional adenoviral protein and its functions are highly regulated by SUMOylation. Although functional consequences of SUMOylated HAdV-C5 E1B-55K are well studied, we lack information on the effects of SUMOylation on homologous E1B-55K proteins from other HAdV species. Here, we show that SUMOylation is a conserved posttranslational modification in most of the E1B-55K proteins, similar to what we know about HAdV-C5 E1B-55K. Moreover, we identify subcellular localization and regulation of p53-dependent transcription as highly conserved SUMOylation-regulated E1B-55K functions. Thus, our results highlight how HAdV proteins might have evolved in different HAdV species with conserved domains involved in virus replication and differing alternative functions and interactions with the host cell machinery. Future research will link these differences and similarities to the diverse pathogenicity and organ tropism of the different HAdV species.

Entities:  

Keywords:  E1B-55K; HAdV species; human adenovirus; large E1B proteins; nuclear export signal (NES); nucleo-cytoplasmic shuttling; p53; p53-dependent transcription; posttranslational modifications; small ubiquitin-like modifier (SUMO)

Mesh:

Substances:

Year:  2021        PMID: 34787461      PMCID: PMC8826807          DOI: 10.1128/JVI.00838-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  57 in total

Review 1.  The biology of the adenovirus E1B 55K protein.

Authors:  Paloma Hidalgo; Wing Hang Ip; Thomas Dobner; Ramón A Gonzalez
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

Review 2.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

3.  Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex.

Authors:  Frédéric Dallaire; Paola Blanchette; Peter Groitl; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

4.  Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein.

Authors:  P Wimmer; P Blanchette; S Schreiner; W Ching; P Groitl; J Berscheminski; P E Branton; H Will; T Dobner
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

5.  CRM1 is an export receptor for leucine-rich nuclear export signals.

Authors:  M Fornerod; M Ohno; M Yoshida; I W Mattaj
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

6.  Role of E1B55K in E4orf6/E1B55K E3 ligase complexes formed by different human adenovirus serotypes.

Authors:  Chi Ying Cheng; Timra Gilson; Peter Wimmer; Sabrina Schreiner; Gary Ketner; Thomas Dobner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

7.  Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5.

Authors:  J G Teodoro; P E Branton
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  KAP1 Is a Host Restriction Factor That Promotes Human Adenovirus E1B-55K SUMO Modification.

Authors:  Carolin Bürck; Andreas Mund; Julia Berscheminski; Lisa Kieweg; Sarah Müncheberg; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

9.  A unique SUMO-2-interacting motif within LANA is essential for KSHV latency.

Authors:  Qiliang Cai; Shen Cai; Caixia Zhu; Suhbash C Verma; Ji-Young Choi; Erle S Robertson
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

10.  SPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection.

Authors:  Sabrina Schreiner; Sarah Kinkley; Carolin Bürck; Andreas Mund; Peter Wimmer; Tobias Schubert; Peter Groitl; Hans Will; Thomas Dobner
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

View more
  1 in total

1.  Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.

Authors:  Marie Fiedler; Wing-Hang Ip; Helga Hofmann-Sieber; Britta Wilkens; Francis K Nkrumah; Wenli Zhang; Anja Ehrhardt; Luca D Bertzbach; Thomas Dobner
Journal:  Viruses       Date:  2022-02-24       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.